Clinical trials
The Australian Parkinson's Mission will conduct an Australian clinical trials program using repurposed drugs (potentially disease modifying drugs that could slow, stop or reverse Parkinson’s progression), integrated with transformative research, to identify and fast-track effective treatments for people with Parkinson’s. The program will run over 5 years.
The APM will be available for all people with Parkinson's — those who have been newly diagnosed, and those living with the disease.
Latest update
We are pleased to announce the Australian Parkinson’s Mission clinical trial (APM001) has now commenced, with eight sites across Australia (in NSW, VIC, SA, WA and QLD), opening for participant enrolment and recruitment beginning in either June or July. Each site will continue enrolment and recruitment activities for 12 months from the initial start date.
If you would like more information on APM’s clinical trial please see the Participant Information Sheet (PDF).
To determine whether you are eligible to participate in the clinical trial, please contact the closest site in your state.
Please note: more details will be added as additional trial locations become active.
|
Site |
Contact name |
Address |
Phone/email |
|---|---|---|---|
|
St Vincent’s Hospital |
Dr Stephen Tisch, Consultant Neurologist |
St Vincent's Hospital 390 Victoria Street |
|
|
Brain and Mind Centre |
Stacey West
|
94 Mallett Street Camperdown NSW 2050
|
+61 (2) 9114 4172
|
If you're interested in participating in the APM001 clinical trial, you will first have to undergo a screening process to determine if you qualify for the trial. Screening may begin over the phone with your closest site. When you contact the site to be screened, there may be a short wait. Please be patient during this time.
- For more information on how each site is handling COVID-19, please talk to your closest APM clinical trial site.
- You can also find more info in our Frequently Asked Questions.